APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atovaquone and Proguanil

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atovaquone and Proguanil Market Analysis and Forecast 2026-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchAtovaquone and Proguanil Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Atovaquone and Proguanil Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atovaquone and Proguanil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atovaquone and Proguanil Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Atovaquone and Proguanil Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Atovaquone and Proguanil market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atovaquone and Proguanil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atovaquone and Proguanil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atovaquone and Proguanil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atovaquone and Proguanil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atovaquone and Proguanil include GSK, Mylan Pharmaceuticals, Hetero and Glenmark, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atovaquone and Proguanil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atovaquone and Proguanil, also provides the sales of main regions and countries. Of the upcoming market potential for Atovaquone and Proguanil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atovaquone and Proguanil sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atovaquone and Proguanil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atovaquone and Proguanil sales, projected growth trends, production technology, application and end-user industry.

Atovaquone and Proguanil Segment by Company

GSK

Mylan Pharmaceuticals

Hetero

Glenmark

Atovaquone and Proguanil Segment by Type

250 mg/100 mg

62.5mg/25mg

Atovaquone and Proguanil Segment by Application

Adult

Paediatric

Atovaquone and Proguanil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atovaquone and Proguanil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atovaquone and Proguanil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atovaquone and Proguanil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atovaquone and Proguanil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atovaquone and Proguanil sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atovaquone and Proguanil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 250 mg/100 mg Major Manufacturers Table 3. 62.5mg/25mg Major Manufacturers Table 4. Global Atovaquone and Proguanil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Paediatric Major Manufacturers Table 7. Atovaquone and Proguanil Industry Trends Table 8. Atovaquone and Proguanil Industry Drivers Table 9. Atovaquone and Proguanil Industry Opportunities and Challenges Table 10. Atovaquone and Proguanil Industry Restraints Table 11. Global Atovaquone and Proguanil Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Atovaquone and Proguanil Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Atovaquone and Proguanil Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Atovaquone and Proguanil Revenue Market Share by Region (2021-2026) Table 15. Global Atovaquone and Proguanil Revenue Market Share by Region (2027-2032) Table 16. Global Atovaquone and Proguanil Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Atovaquone and Proguanil Sales by Region (2021-2026) & (W Units) Table 18. Global Atovaquone and Proguanil Sales by Region (2027-2032) & (W Units) Table 19. Global Atovaquone and Proguanil Sales Market Share by Region (2021-2026) Table 20. Global Atovaquone and Proguanil Sales Market Share by Region (2027-2032) Table 21. Global Atovaquone and Proguanil Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Atovaquone and Proguanil Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Atovaquone and Proguanil Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2021-2026) Table 25. Global Atovaquone and Proguanil Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Atovaquone and Proguanil Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Atovaquone and Proguanil Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Atovaquone and Proguanil Manufacturers, Product Type & Application Table 29. Global Atovaquone and Proguanil Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Atovaquone and Proguanil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Atovaquone and Proguanil Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Atovaquone and Proguanil Revenue Market Share by Type (2021-2026) Table 36. Global Atovaquone and Proguanil Revenue Market Share by Type (2027-2032) Table 37. Global Atovaquone and Proguanil Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 39. Global Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 40. Global Atovaquone and Proguanil Sales Market Share by Type (2021-2026) Table 41. Global Atovaquone and Proguanil Sales Market Share by Type (2027-2032) Table 42. Global Atovaquone and Proguanil Price by Type (2021-2026) & (US$/Unit) Table 43. Global Atovaquone and Proguanil Price by Type (2027-2032) & (US$/Unit) Table 44. Global Atovaquone and Proguanil Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Atovaquone and Proguanil Revenue Market Share by Application (2021-2026) Table 48. Global Atovaquone and Proguanil Revenue Market Share by Application (2027-2032) Table 49. Global Atovaquone and Proguanil Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 51. Global Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 52. Global Atovaquone and Proguanil Sales Market Share by Application (2021-2026) Table 53. Global Atovaquone and Proguanil Sales Market Share by Application (2027-2032) Table 54. Global Atovaquone and Proguanil Price by Application (2021-2026) & (US$/Unit) Table 55. Global Atovaquone and Proguanil Price by Application (2027-2032) & (US$/Unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. GSK Atovaquone and Proguanil Product Portfolio Table 60. GSK Recent Development Table 61. Mylan Pharmaceuticals Company Information Table 62. Mylan Pharmaceuticals Business Overview Table 63. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio Table 65. Mylan Pharmaceuticals Recent Development Table 66. Hetero Company Information Table 67. Hetero Business Overview Table 68. Hetero Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Hetero Atovaquone and Proguanil Product Portfolio Table 70. Hetero Recent Development Table 71. Glenmark Company Information Table 72. Glenmark Business Overview Table 73. Glenmark Atovaquone and Proguanil Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Glenmark Atovaquone and Proguanil Product Portfolio Table 75. Glenmark Recent Development Table 76. North America Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 79. North America Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 80. North America Atovaquone and Proguanil Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Atovaquone and Proguanil Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 85. North America Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 86. North America Atovaquone and Proguanil Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Atovaquone and Proguanil Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Atovaquone and Proguanil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Atovaquone and Proguanil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 92. North America Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 93. North America Atovaquone and Proguanil Sales by Country (2027-2032) & (W Units) Table 94. North America Atovaquone and Proguanil Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Atovaquone and Proguanil Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 97. Canada Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 98. Europe Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 101. Europe Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 102. Europe Atovaquone and Proguanil Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Atovaquone and Proguanil Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 107. Europe Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 108. Europe Atovaquone and Proguanil Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Atovaquone and Proguanil Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Atovaquone and Proguanil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Atovaquone and Proguanil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 114. Europe Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 115. Europe Atovaquone and Proguanil Sales by Country (2027-2032) & (W Units) Table 116. Europe Atovaquone and Proguanil Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Atovaquone and Proguanil Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 119. France Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 120. U.K. Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 121. Italy Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 123. China Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 124. China Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 125. China Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 126. China Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 127. China Atovaquone and Proguanil Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Atovaquone and Proguanil Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 130. China Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 131. China Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 132. China Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 133. China Atovaquone and Proguanil Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Atovaquone and Proguanil Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 138. Asia Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 139. Asia Atovaquone and Proguanil Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Atovaquone and Proguanil Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 144. Asia Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 145. Asia Atovaquone and Proguanil Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Atovaquone and Proguanil Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Atovaquone and Proguanil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Atovaquone and Proguanil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 151. Asia Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 152. Asia Atovaquone and Proguanil Sales by Country (2027-2032) & (W Units) Table 153. Asia Atovaquone and Proguanil Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Atovaquone and Proguanil Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 156. South Korea Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 157. India Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 158. Australia Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Atovaquone and Proguanil Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Atovaquone and Proguanil Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Atovaquone and Proguanil Sales by Type (2021-2026) & (W Units) Table 164. SAMEA Atovaquone and Proguanil Sales by Type (2027-2032) & (W Units) Table 165. SAMEA Atovaquone and Proguanil Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Atovaquone and Proguanil Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Atovaquone and Proguanil Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Atovaquone and Proguanil Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Atovaquone and Proguanil Sales by Application (2021-2026) & (W Units) Table 170. SAMEA Atovaquone and Proguanil Sales by Application (2027-2032) & (W Units) Table 171. SAMEA Atovaquone and Proguanil Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Atovaquone and Proguanil Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Atovaquone and Proguanil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Atovaquone and Proguanil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. SAMEA Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 178. SAMEA Atovaquone and Proguanil Sales by Country (2027-2032) & (W Units) Table 179. SAMEA Atovaquone and Proguanil Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Atovaquone and Proguanil Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 182. Argentina Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 183. Chile Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 184. Colombia Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 185. Peru Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 187. Israel Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 188. UAE Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 189. Turkey Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 190. Iran Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 191. Egypt Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Atovaquone and Proguanil Distributors List Table 195. Atovaquone and Proguanil Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Atovaquone and Proguanil Image Figure 2. Global Atovaquone and Proguanil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atovaquone and Proguanil Market Size Share 2021 VS 2025 VS 2032 Figure 4. 250 mg/100 mg Image Figure 5. 62.5mg/25mg Image Figure 6. Global Atovaquone and Proguanil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Atovaquone and Proguanil Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Paediatric Image Figure 10. Global Atovaquone and Proguanil Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Atovaquone and Proguanil Revenue (2021-2032) & (US$ Million) Figure 12. Global Atovaquone and Proguanil Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Atovaquone and Proguanil Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Atovaquone and Proguanil Revenue Market Share by Region (2021-2032) Figure 15. Global Atovaquone and Proguanil Sales (2021-2032) & (W Units) Figure 16. Global Atovaquone and Proguanil Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Atovaquone and Proguanil Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Atovaquone and Proguanil Sales YoY (2021-2032) & (W Units) Figure 19. Europe Atovaquone and Proguanil Sales YoY (2021-2032) & (W Units) Figure 20. China Atovaquone and Proguanil Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Atovaquone and Proguanil Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Atovaquone and Proguanil Sales YoY (2021-2032) & (W Units) Figure 23. Global Atovaquone and Proguanil Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Atovaquone and Proguanil Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Atovaquone and Proguanil Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Atovaquone and Proguanil Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Atovaquone and Proguanil Revenue Market Share by Type (2021-2032) Figure 29. Global Atovaquone and Proguanil Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Atovaquone and Proguanil Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Atovaquone and Proguanil Sales Market Share by Type (2021-2032) Figure 32. Global Atovaquone and Proguanil Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Atovaquone and Proguanil Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Atovaquone and Proguanil Revenue Market Share by Application (2021-2032) Figure 35. Global Atovaquone and Proguanil Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Atovaquone and Proguanil Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Atovaquone and Proguanil Sales Market Share by Application (2021-2032) Figure 38. North America Atovaquone and Proguanil Revenue Share by Type (2021-2032) Figure 39. North America Atovaquone and Proguanil Sales Share by Type (2021-2032) Figure 40. North America Atovaquone and Proguanil Revenue Share by Application (2021-2032) Figure 41. North America Atovaquone and Proguanil Sales Share by Application (2021-2032) Figure 42. North America Atovaquone and Proguanil Revenue Share by Country (2021-2032) Figure 43. North America Atovaquone and Proguanil Sales Share by Country (2021-2032) Figure 44. Europe Atovaquone and Proguanil Revenue Share by Type (2021-2032) Figure 45. Europe Atovaquone and Proguanil Sales Share by Type (2021-2032) Figure 46. Europe Atovaquone and Proguanil Revenue Share by Application (2021-2032) Figure 47. Europe Atovaquone and Proguanil Sales Share by Application (2021-2032) Figure 48. Europe Atovaquone and Proguanil Revenue Share by Country (2021-2032) Figure 49. Europe Atovaquone and Proguanil Sales Share by Country (2021-2032) Figure 50. China Atovaquone and Proguanil Revenue Share by Type (2021-2032) Figure 51. China Atovaquone and Proguanil Sales Share by Type (2021-2032) Figure 52. China Atovaquone and Proguanil Revenue Share by Application (2021-2032) Figure 53. China Atovaquone and Proguanil Sales Share by Application (2021-2032) Figure 54. Asia Atovaquone and Proguanil Revenue Share by Type (2021-2032) Figure 55. Asia Atovaquone and Proguanil Sales Share by Type (2021-2032) Figure 56. Asia Atovaquone and Proguanil Revenue Share by Application (2021-2032) Figure 57. Asia Atovaquone and Proguanil Sales Share by Application (2021-2032) Figure 58. Asia Atovaquone and Proguanil Revenue Share by Country (2021-2032) Figure 59. Asia Atovaquone and Proguanil Sales Share by Country (2021-2032) Figure 60. SAMEA Atovaquone and Proguanil Revenue Share by Type (2021-2032) Figure 61. SAMEA Atovaquone and Proguanil Sales Share by Type (2021-2032) Figure 62. SAMEA Atovaquone and Proguanil Revenue Share by Application (2021-2032) Figure 63. SAMEA Atovaquone and Proguanil Sales Share by Application (2021-2032) Figure 64. SAMEA Atovaquone and Proguanil Revenue Share by Country (2021-2032) Figure 65. SAMEA Atovaquone and Proguanil Sales Share by Country (2021-2032) Figure 66. Atovaquone and Proguanil Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Atovaquone and Proguanil Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 250 mg/100 mg
  • 62.5mg/25mg
Applications
  • Adult
  • Paediatric
Companies covered
  • GSK
  • Mylan Pharmaceuticals
  • Hetero
  • Glenmark

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atovaquone and Proguanil Market by Type
  3. 1.2.1 Global Atovaquone and Proguanil Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 250 mg/100 mg
  5. 1.2.3 62.5mg/25mg
  6. 1.3 Atovaquone and Proguanil Market by Application
  7. 1.3.1 Global Atovaquone and Proguanil Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Paediatric
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Atovaquone and Proguanil Market Dynamics
  1. 2.1 Atovaquone and Proguanil Industry Trends
  2. 2.2 Atovaquone and Proguanil Industry Drivers
  3. 2.3 Atovaquone and Proguanil Industry Opportunities and Challenges
  4. 2.4 Atovaquone and Proguanil Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atovaquone and Proguanil Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atovaquone and Proguanil Revenue by Region
  3. 3.2.1 Global Atovaquone and Proguanil Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atovaquone and Proguanil Revenue by Region (2021-2026)
  5. 3.2.3 Global Atovaquone and Proguanil Revenue by Region (2027-2032)
  6. 3.2.4 Global Atovaquone and Proguanil Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atovaquone and Proguanil Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atovaquone and Proguanil Sales by Region
  9. 3.4.1 Global Atovaquone and Proguanil Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atovaquone and Proguanil Sales by Region (2021-2026)
  11. 3.4.3 Global Atovaquone and Proguanil Sales by Region (2027-2032)
  12. 3.4.4 Global Atovaquone and Proguanil Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atovaquone and Proguanil Revenue by Manufacturers
  2. 4.1.1 Global Atovaquone and Proguanil Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atovaquone and Proguanil Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atovaquone and Proguanil Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atovaquone and Proguanil Sales by Manufacturers
  6. 4.2.1 Global Atovaquone and Proguanil Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atovaquone and Proguanil Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atovaquone and Proguanil Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atovaquone and Proguanil Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atovaquone and Proguanil Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atovaquone and Proguanil Manufacturers, Product Type & Application
  13. 4.7 Global Atovaquone and Proguanil Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atovaquone and Proguanil Market CR5 and HHI
  16. 4.8.2 2025 Atovaquone and Proguanil Tier 1, Tier 2, and Tier 3
5 Atovaquone and Proguanil Market by Type
  1. 5.1 Global Atovaquone and Proguanil Revenue by Type
  2. 5.1.1 Global Atovaquone and Proguanil Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atovaquone and Proguanil Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atovaquone and Proguanil Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atovaquone and Proguanil Sales by Type
  6. 5.2.1 Global Atovaquone and Proguanil Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atovaquone and Proguanil Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Atovaquone and Proguanil Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atovaquone and Proguanil Price by Type
6 Atovaquone and Proguanil Market by Application
  1. 6.1 Global Atovaquone and Proguanil Revenue by Application
  2. 6.1.1 Global Atovaquone and Proguanil Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atovaquone and Proguanil Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atovaquone and Proguanil Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atovaquone and Proguanil Sales by Application
  6. 6.2.1 Global Atovaquone and Proguanil Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atovaquone and Proguanil Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Atovaquone and Proguanil Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atovaquone and Proguanil Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Atovaquone and Proguanil Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Mylan Pharmaceuticals
  8. 7.2.1 Mylan Pharmaceuticals Company Information
  9. 7.2.2 Mylan Pharmaceuticals Business Overview
  10. 7.2.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio
  12. 7.2.5 Mylan Pharmaceuticals Recent Developments
  13. 7.3 Hetero
  14. 7.3.1 Hetero Company Information
  15. 7.3.2 Hetero Business Overview
  16. 7.3.3 Hetero Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hetero Atovaquone and Proguanil Product Portfolio
  18. 7.3.5 Hetero Recent Developments
  19. 7.4 Glenmark
  20. 7.4.1 Glenmark Company Information
  21. 7.4.2 Glenmark Business Overview
  22. 7.4.3 Glenmark Atovaquone and Proguanil Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glenmark Atovaquone and Proguanil Product Portfolio
  24. 7.4.5 Glenmark Recent Developments
8 North America
  1. 8.1 North America Atovaquone and Proguanil Market Size by Type
  2. 8.1.1 North America Atovaquone and Proguanil Revenue by Type (2021-2032)
  3. 8.1.2 North America Atovaquone and Proguanil Sales by Type (2021-2032)
  4. 8.1.3 North America Atovaquone and Proguanil Price by Type (2021-2032)
  5. 8.2 North America Atovaquone and Proguanil Market Size by Application
  6. 8.2.1 North America Atovaquone and Proguanil Revenue by Application (2021-2032)
  7. 8.2.2 North America Atovaquone and Proguanil Sales by Application (2021-2032)
  8. 8.2.3 North America Atovaquone and Proguanil Price by Application (2021-2032)
  9. 8.3 North America Atovaquone and Proguanil Market Size by Country
  10. 8.3.1 North America Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atovaquone and Proguanil Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Atovaquone and Proguanil Market Size by Type
  2. 9.1.1 Europe Atovaquone and Proguanil Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atovaquone and Proguanil Sales by Type (2021-2032)
  4. 9.1.3 Europe Atovaquone and Proguanil Price by Type (2021-2032)
  5. 9.2 Europe Atovaquone and Proguanil Market Size by Application
  6. 9.2.1 Europe Atovaquone and Proguanil Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atovaquone and Proguanil Sales by Application (2021-2032)
  8. 9.2.3 Europe Atovaquone and Proguanil Price by Application (2021-2032)
  9. 9.3 Europe Atovaquone and Proguanil Market Size by Country
  10. 9.3.1 Europe Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atovaquone and Proguanil Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Atovaquone and Proguanil Market Size by Type
  2. 10.1.1 China Atovaquone and Proguanil Revenue by Type (2021-2032)
  3. 10.1.2 China Atovaquone and Proguanil Sales by Type (2021-2032)
  4. 10.1.3 China Atovaquone and Proguanil Price by Type (2021-2032)
  5. 10.2 China Atovaquone and Proguanil Market Size by Application
  6. 10.2.1 China Atovaquone and Proguanil Revenue by Application (2021-2032)
  7. 10.2.2 China Atovaquone and Proguanil Sales by Application (2021-2032)
  8. 10.2.3 China Atovaquone and Proguanil Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atovaquone and Proguanil Market Size by Type
  2. 11.1.1 Asia Atovaquone and Proguanil Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atovaquone and Proguanil Sales by Type (2021-2032)
  4. 11.1.3 Asia Atovaquone and Proguanil Price by Type (2021-2032)
  5. 11.2 Asia Atovaquone and Proguanil Market Size by Application
  6. 11.2.1 Asia Atovaquone and Proguanil Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atovaquone and Proguanil Sales by Application (2021-2032)
  8. 11.2.3 Asia Atovaquone and Proguanil Price by Application (2021-2032)
  9. 11.3 Asia Atovaquone and Proguanil Market Size by Country
  10. 11.3.1 Asia Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atovaquone and Proguanil Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atovaquone and Proguanil Market Size by Type
  2. 12.1.1 SAMEA Atovaquone and Proguanil Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atovaquone and Proguanil Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atovaquone and Proguanil Price by Type (2021-2032)
  5. 12.2 SAMEA Atovaquone and Proguanil Market Size by Application
  6. 12.2.1 SAMEA Atovaquone and Proguanil Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atovaquone and Proguanil Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atovaquone and Proguanil Price by Application (2021-2032)
  9. 12.3 SAMEA Atovaquone and Proguanil Market Size by Country
  10. 12.3.1 SAMEA Atovaquone and Proguanil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atovaquone and Proguanil Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atovaquone and Proguanil Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atovaquone and Proguanil Value Chain Analysis
  2. 13.1.1 Atovaquone and Proguanil Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atovaquone and Proguanil Production Mode & Process
  6. 13.2 Atovaquone and Proguanil Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atovaquone and Proguanil Distributors
  9. 13.2.3 Atovaquone and Proguanil Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst